Semaglutide Reduced Risks of Major Kidney Outcomes Irrespective of CKD Severity in the FLOW Trial

Authors: Katherine R. Tuttle, Johannes F. Mann, Ekaterina Sokareva, Brian Rayner, Giuseppe Pugliese, Richard E. Pratley, Vlado Perkovic, Kenneth W. Mahaffey, Naoki Kashihara, Ole K. Jeppesen, Janusz Gumprecht, Ricardo Correa-Rotter, David Cherney, Heidrun Bosch-Traberg, Mustafa Arici, Peter Rossing

Published: 2024-10-28

DOI: 10.1681/asn.2024bjyvcgfe

Keywords: No keywords found.

Abstract:
No abstract found.

Source: